U S Department of Health and Human Services Improving the health, safety and well-being of America
  CMS Home > Medicare > Medicare Coverage - General Information > Medicare Coverage Database > Search Home > Search Results > View LCD

Medicare Coverage Database

LCD for Diagnostic Pap Smear (L1210)


Superceded Stamp
Please note: This version is not currently in effect.

Please note: If you are printing this document and it is truncated on the right margin, please try printing landscape.

Contractor Information
Superceded StampSuperceded Stamp
Contractor Name back to top
Palmetto GBA 
Contractor Number back to top
00380 
Contractor Type back to top
FI 


LCD Information
Superceded StampSuperceded Stamp
LCD ID Number back to top
L1210 
 
LCD Title back to top
Diagnostic Pap Smear 
 
Contractor's Determination Number back to top
90A-0034-L 
 
AMA CPT / ADA CDT Copyright Statement back to top
CPT codes, descriptions and other data only are copyright 2009 American Medical Association (or such other date of publication of CPT). All Rights Reserved. Applicable FARS/DFARS Clauses Apply. Current Dental Terminology, (CDT) (including procedure codes, nomenclature, descriptors and other data contained therein) is copyright by the American Dental Association. © 2002, 2004 American Dental Association. All rights reserved. Applicable FARS/DFARS apply.  
 
CMS National Coverage Policy back to top
Title XVIII of the Social Security Act, §1862 (a)(1)(A) allows coverage and payment for only those services that are considered to be reasonable and necessary for the diagnosis or treatment of illness or injury or to improve the functioning of a malformed body member.

Title XVIII of the Social Security Act, §1862 (a)(7) excludes routine physical examinations.

CMS Manual System, Pub 100-03, Medicare National Coverage Determinations Manual, Chapter 1, Part 3, §190.2 and Part 4, §230.11

CMS Manual System, Pub. 100-08, Medicare Program Integrity, Transmittal 63, dated January 23, 2004, Change Request 3010
 
 
Primary Geographic Jurisdiction back to top
South Carolina
 
 
Oversight Region back to top
Region IV
 
 
Original Determination Effective Date back to top
For services performed on or after 11/15/1997  
 
Original Determination Ending Date back to top
 
 
Revision Effective Date back to top
For services performed on or after 10/01/2008  
 
Revision Ending Date back to top
09/02/2009 
 
Indications and Limitations of Coverage and/or Medical Necessity back to top
Pap Smear (Papanicolaou) Smear/Test is a cytological examination of a vaginal smear for early detection of cancer (especially of the cervix and uterus) employing exfoliated cells and special staining techniques, which differentiates disease tissue.

The coverage criteria for Diagnostic Pap smear can be found in the CMS Manual System, Pub. 100-03, Medicare National Coverage Determinations (Internet-Only Manual). 
 


Coding Information
Superceded StampSuperceded Stamp
Bill Type Codes: back to top

Contractors may specify Bill Types to help providers identify those Bill Types typically used to report this service. Absence of a Bill Type does not guarantee that the policy does not apply to that Bill Type. Complete absence of all Bill Types indicates that coverage is not influenced by Bill Type and the policy should be assumed to apply equally to all claims.

12x Hospital-inpatient or home health visits (Part B only)
13x Hospital-outpatient (HHA-A also) (under OPPS 13X must be used for ASC claims submitted for OPPS payment -- eff. 7/00)
14x Non-Patient Laboratory Specimens
18x Hospital-swing beds
21x SNF-inpatient, Part A
22x SNF-inpatient or home health visits (Part B only)
23x SNF-outpatient (HHA-A also)
71x Clinic-rural health
73x Clinic-independent provider based FQHC (eff 10/91)
85x Special facility or ASC surgery-rural primary care hospital (eff 10/94)
 
 
Revenue Codes: back to top

Contractors may specify Revenue Codes to help providers identify those Revenue Codes typically used to report this service. In most instances Revenue Codes are purely advisory; unless specified in the policy services reported under other Revenue Codes are equally subject to this coverage determination. Complete absence of all Revenue Codes indicates that coverage is not influenced by Revenue Code and the policy should be assumed to apply equally to all Revenue Codes.


0311 Laboratory pathological-cytology
0923 Other diagnostic services-pap smear
 
 
CPT/HCPCS Codes back to top

88141 Cytopath, c/v, interpret
88142 Cytopath, c/v, thin layer
88143 Cytopath c/v thin layer redo
88147 Cytopath, c/v, automated
88148 Cytopath, c/v, auto rescreen
88150 Cytopath, c/v, manual
88152 Cytopath, c/v, auto redo
88153 Cytopath, c/v, redo
88154 Cytopath, c/v, select
88155 Cytopath, c/v, index add-on
88164 Cytopath tbs, c/v, manual
88165 Cytopath tbs, c/v, redo
88166 Cytopath tbs, c/v, auto redo
88167 Cytopath tbs, c/v, select
88174 Cytopath, c/v auto, in fluid
88175 Cytopath c/v auto fluid redo
 
 
ICD-9 Codes that Support Medical Necessity back to top

054.10 GENITAL HERPES UNSPECIFIED
054.11 HERPETIC VULVOVAGINITIS
054.12 HERPETIC ULCERATION OF VULVA
078.0 MOLLUSCUM CONTAGIOSUM
078.10 VIRAL WARTS UNSPECIFIED
078.11 CONDYLOMA ACUMINATUM
078.19 OTHER SPECIFIED VIRAL WARTS
090.0 - 099.9 EARLY CONGENITAL SYPHILIS SYMPTOMATIC - VENEREAL DISEASE UNSPECIFIED
112.1 CANDIDIASIS OF VULVA AND VAGINA
112.2 CANDIDIASIS OF OTHER UROGENITAL SITES
171.6 MALIGNANT NEOPLASM OF CONNECTIVE AND OTHER SOFT TISSUE OF PELVIS
179 MALIGNANT NEOPLASM OF UTERUS-PART UNS
180.0 - 180.9 MALIGNANT NEOPLASM OF ENDOCERVIX - MALIGNANT NEOPLASM OF CERVIX UTERI UNSPECIFIED SITE
181 MALIGNANT NEOPLASM OF PLACENTA
182.0 - 182.8 MALIGNANT NEOPLASM OF CORPUS UTERI EXCEPT ISTHMUS - MALIGNANT NEOPLASM OF OTHER SPECIFIED SITES OF BODY OF UTERUS
183.0 - 183.8 MALIGNANT NEOPLASM OF OVARY - MALIGNANT NEOPLASM OF OTHER SPECIFIED SITES OF UTERINE ADNEXA
184.0 - 184.9 MALIGNANT NEOPLASM OF VAGINA - MALIGNANT NEOPLASM OF FEMALE GENITAL ORGAN SITE UNSPECIFIED
195.3 MALIGNANT NEOPLASM OF PELVIS
198.6 SECONDARY MALIGNANT NEOPLASM OF OVARY
198.82 SECONDARY MALIGNANT NEOPLASM OF GENITAL ORGANS
218.0 - 218.9 SUBMUCOUS LEIOMYOMA OF UTERUS - LEIOMYOMA OF UTERUS UNSPECIFIED
219.0 - 219.9 BENIGN NEOPLASM OF CERVIX UTERI - BENIGN NEOPLASM OF UTERUS PART UNSPECIFIED
220 BENIGN NEOPLASM OF OVARY
221.0 - 221.9 BENIGN NEOPLASM OF FALLOPIAN TUBE AND UTERINE LIGAMENTS - BENIGN NEOPLASM OF FEMALE GENITAL ORGAN SITE UNSPECIFIED
233.1 CARCINOMA IN SITU OF CERVIX UTERI
233.2 CARCINOMA IN SITU OF OTHER AND UNSPECIFIED PARTS OF UTERUS
233.30 CARCINOMA IN SITU, UNSPECIFIED FEMALE GENITAL ORGAN
233.31 CARCINOMA IN SITU, VAGINA
233.39 CARCINOMA IN SITU, OTHER FEMALE GENITAL ORGAN
233.9 CARCINOMA IN SITU OF OTHER AND UNSPECIFIED URINARY ORGANS
236.0 - 236.3 NEOPLASM OF UNCERTAIN BEHAVIOR OF UTERUS - NEOPLASM OF UNCERTAIN BEHAVIOR OF OTHER AND UNSPECIFIED FEMALE GENITAL ORGANS
256.0 - 256.9 HYPERESTROGENISM - UNSPECIFIED OVARIAN DYSFUNCTION
616.0 CERVICITIS AND ENDOCERVICITIS
616.10 - 616.11 VAGINITIS AND VULVOVAGINITIS UNSPECIFIED - VAGINITIS AND VULVOVAGINITIS IN DISEASES CLASSIFIED ELSEWHERE
616.2 CYST OF BARTHOLIN'S GLAND
616.50 - 616.51 ULCERATION OF VULVA UNSPECIFIED - ULCERATION OF VULVA IN DISEASES CLASSIFIED ELSEWHERE
616.81 MUCOSITIS (ULCERATIVE) OF CERVIX, VAGINA, AND VULVA
616.89 OTHER INFLAMMATORY DISEASE OF CERVIX, VAGINA AND VULVA
616.9 UNSPECIFIED INFLAMMATORY DISEASE OF CERVIX VAGINA AND VULVA
617.0 - 617.9 ENDOMETRIOSIS OF UTERUS - ENDOMETRIOSIS SITE UNSPECIFIED
620.0 FOLLICULAR CYST OF OVARY
620.1 CORPUS LUTEUM CYST OR HEMATOMA
620.2 OTHER AND UNSPECIFIED OVARIAN CYST
620.8 OTHER NONINFLAMMATORY DISORDERS OF OVARY FALLOPIAN TUBE AND BROAD LIGAMENT
621.0 POLYP OF CORPUS UTERI
621.1 CHRONIC SUBINVOLUTION OF UTERUS
621.2 HYPERTROPHY OF UTERUS
621.8 OTHER SPECIFIED DISORDERS OF UTERUS NOT ELSEWHERE CLASSIFIED
622.0 EROSION AND ECTROPION OF CERVIX
622.10 DYSPLASIA OF CERVIX, UNSPECIFIED
622.11 MILD DYSPLASIA OF CERVIX
622.12 MODERATE DYSPLASIA OF CERVIX
622.7 MUCOUS POLYP OF CERVIX
622.8 OTHER SPECIFIED NONINFLAMMATORY DISORDERS OF CERVIX
622.9 UNSPECIFIED NONINFLAMMATORY DISORDER OF CERVIX
623.0 DYSPLASIA OF VAGINA
623.5 LEUKORRHEA NOT SPECIFIED AS INFECTIVE
623.7 POLYP OF VAGINA
623.8 OTHER SPECIFIED NONINFLAMMATORY DISORDERS OF VAGINA
623.9 UNSPECIFIED NONINFLAMMATORY DISORDER OF VAGINA
624.6 POLYP OF LABIA AND VULVA
624.8 OTHER SPECIFIED NONINFLAMMATORY DISORDERS OF VULVA AND PERINEUM
625.70 VULVODYNIA, UNSPECIFIED
625.71 VULVAR VESTIBULITIS
625.79 OTHER VULVODYNIA
626.2 EXCESSIVE OR FREQUENT MENSTRUATION
626.6 METRORRHAGIA
626.7 POSTCOITAL BLEEDING
626.8 OTHER DISORDERS OF MENSTRUATION AND OTHER ABNORMAL BLEEDING FROM FEMALE GENITAL TRACT
626.9 UNSPECIFIED DISORDERS OF MENSTRUATION AND OTHER ABNORMAL BLEEDING FROM FEMALE GENITAL TRACT
627.1 POSTMENOPAUSAL BLEEDING
627.2 SYMPTOMATIC MENOPAUSAL OR FEMALE CLIMACTERIC STATES
627.3 POSTMENOPAUSAL ATROPHIC VAGINITIS
627.8 OTHER SPECIFIED MENOPAUSAL AND POSTMENOPAUSAL DISORDERS
627.9 UNSPECIFIED MENOPAUSAL AND POSTMENOPAUSAL DISORDER
628.0 - 628.9 INFERTILITY FEMALE ASSOCIATED WITH ANOVULATION - INFERTILITY FEMALE OF UNSPECIFIED ORIGIN
649.70 CERVICAL SHORTENING, UNSPECIFIED AS TO EPISODE OF CARE OR NOT APPLICABLE
649.71 CERVICAL SHORTENING, DELIVERED, WITH OR WITHOUT MENTION OF ANTEPARTUM CONDITION
649.73 CERVICAL SHORTENING, ANTEPARTUM CONDITION OR COMPLICATION
654.10 - 654.14 TUMORS OF BODY OF UTERUS UNSPECIFIED AS TO EPISODE OF CARE IN PREGNANCY - TUMORS OF BODY OF UTERUS POSTPARTUM CONDITION OR COMPLICATION
795.00 ABNORMAL GLANDULAR PAPANICOLAOU SMEAR OF CERVIX
795.01 PAPANICOLAOU SMEAR OF CERVIX WITH ATYPICAL SQUAMOUS CELLS OF UNDETERMINED SIGNIFICANCE (ASC-US)
795.02 PAPANICOLAOU SMEAR OF CERVIX WITH ATYPICAL SQUAMOUS CELLS CANNOT EXCLUDE HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESION (ASC-H)
795.03 PAPANICOLAOU SMEAR OF CERVIX WITH LOW GRADE SQUAMOUS INTRAEPITHELIAL LESION (LGSIL)
795.04 PAPANICOLAOU SMEAR OF CERVIX WITH HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESION (HGSIL)
795.05 CERVICAL HIGH RISK HUMAN PAPILLOMAVIRUS (HPV) DNA TEST POSITIVE
795.06 PAPANICOLAOU SMEAR OF CERVIX WITH CYTOLOGIC EVIDENCE OF MALIGNANCY
795.07 SATISFACTORY CERVICAL SMEAR BUT LACKING TRANSFORMATION ZONE
795.08 UNSATISFACTORY CERVICAL CYTOLOGY SMEAR
795.09 OTHER ABNORMAL PAPANICOLAOU SMEAR OF CERVIX AND CERVICAL HPV
795.10 ABNORMAL GLANDULAR PAPANICOLAOU SMEAR OF VAGINA
795.11 PAPANICOLAOU SMEAR OF VAGINA WITH ATYPICAL SQUAMOUS CELLS OF UNDETERMINED SIGNIFICANCE (ASC-US)
795.12 PAPANICOLAOU SMEAR OF VAGINA WITH ATYPICAL SQUAMOUS CELLS CANNOT EXCLUDE HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESION (ASC-H)
795.13 PAPANICOLAOU SMEAR OF VAGINA WITH LOW GRADE SQUAMOUS INTRAEPITHELIAL LESION (LGSIL)
795.14 PAPANICOLAOU SMEAR OF VAGINA WITH HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESION (HGSIL)
795.15 VAGINAL HIGH RISK HUMAN PAPILLOMAVIRUS (HPV) DNA TEST POSITIVE
795.16 PAPANICOLAOU SMEAR OF VAGINA WITH CYTOLOGIC EVIDENCE OF MALIGNANCY
795.18 UNSATISFACTORY VAGINAL CYTOLOGY SMEAR
795.19 OTHER ABNORMAL PAPANICOLAOU SMEAR OF VAGINA AND VAGINAL HPV
 
 
Diagnoses that Support Medical Necessity back to top
N/A 
 
ICD-9 Codes that DO NOT Support Medical Necessity back to top
N/A
 
 
ICD-9 Codes that DO NOT Support Medical Necessity Asterisk Explanation back to top
 
 
Diagnoses that DO NOT Support Medical Necessity back to top
N/A 


General Information
Superceded StampSuperceded Stamp
Documentation Requirements back to top
1. Documentation supporting the medical necessity should be legible, maintained in the patient’s medical record, and must be made available to the Intermediary upon request.

2. The physician must order diagnostic Pap Smears and the documentation must support the medical necessity for the test being done.
 
 
Appendices back to top
N/A 
 
Utilization Guidelines back to top
This policy does not address Pap smears covered under the screening benefit described in §4102 of the Balanced Budget Amendment of 1997 (BBA) 
 
Sources of Information and Basis for Decision back to top
Carr B, Bradshaw K. Disorders of the Ovary and Female Reproductive Tract. In: Fauci AS, Braunwald E, Kasper D, et al. eds. Harrison’s Principles of Internal Medicine. 16th ed. New York, NY: McGraw-Hill; 2005:2207-2208.
 
 
Advisory Committee Meeting Notes back to top
This policy does not reflect the sole opinion of the contractor or Contractor Medical Director. Although the final decision rests with the Intermediary, this policy was developed in cooperation with advisory groups, which include representatives from the affected provider community. Advisory Committee Meeting Date: N/A. 
 
Start Date of Comment Period back to top
06/28/1997 
 
End Date of Comment Period back to top
08/11/1997 
 
Start Date of Notice Period back to top
10/15/1997 
 
Revision History Number back to top
Revision #15, 10/01/2008
Revision #14, 10/01/2007
Revision #13, 10/01/2006
Revision #12, 01/01/2006
Revision #11, 08/19/2005
Revision #10, 08/19/2005
Revision #9, 11/22/2004
Revision #8, 10/01/2004
Revision #7, 11/28/2003
Revision #6, 10/01/2003
Revision #5, 08/23/2002
Revision #4, 08/10/2001
Revision #3, 05/23/1999
Revision #2, 02/24/1999
Revision #1 
 
Revision History Explanation back to top
Revision #15, 10/01/2008
Under AMA/CPT & ADA/CDT Copyright Statement changed the copyright date from 2007 to 2008. Under ICD-9 Codes That Support Medical Necessity added ICD-9 codes 625.70, 625.71, 625.79, 649.70, 649.71, 649.73,795.07, and 795.08. ICD-9 code 795.1 was extended to a 5th digit to now read 795.10, 795.11, 795.12, 795.13, 795.14, 795.15, 795.16, 795.18, and 795.19.This revision becomes effective 10/01/2008.


Revision #14, 10/01/2007
Under AMA/ CPT & ADA/CDT Copyright Statement changed the copyright date from 2006 to 2007. Under CMS National Coverage Policy changed the publication number for the referenced manual from “100-3” to now read “100-03”. Under Indications and Limitations of Coverage and/or Medical Necessity changed the publication number for the referenced manual from “100-3” to now read “100-03”. Under ICD-9 Codes That Support Medical Necessity ICD-9 code 233.3 was extended to a 5th digit to now read 233.30, 233.31 and 233.39. During the ICD-9 code annual update review of this Local Coverage Determination (LCD) it was noted that ICD-9 code 233.0 was inadvertently added to the LCD. This ICD-9 code will be deleted. Under Sources of Information and Basis for Decision deleted the cited national policy and added the following reference: Carr B, Bradshaw K. Disorders of the Ovary and Female Reproductive Tract. In: Fauci AS, Braunwald E, Kasper D, et al. eds. Harrison’s Principles of Internal Medicine. 16th ed. New York, NY: McGraw-Hill; 2005:2207-2208. This policy was reviewed for annual validation. This revision becomes effective 10/01/2007.

Revision #13, 10/01/2006
Under AMA/ CPT & ADA/CDT Copyright Statement changed the copyright date from 2005 to 2006. Under CMS National Coverage Policy added Title XVIII of the Social Security Act, §1862 (a)(7)and changed Transmittal “62” to now read “63” for Change Request 3010. Under ICD-9 Codes That Support Medical Necessity ICD-9 code 616.8 extended to now read 616.81 and 616.89 and added ICD-9 code 795.06. Under Advisory Committee Meeting Notes changed “affected providers” to “the affected provider community.” This policy was reviewed for annual validation. This revision becomes effective 10/01/2006.

Revision #12, 01/01/2006
Under CMS National Coverage Policy deleted Change Request 2592. Under CPT/HCPCS Codes changed the verbiage to short descriptors.Under Does the "CPT 30% Coding Rule" Apply the verbiage was changed to "Yes". This revision becomes effective January 1, 2006.

Revision #11, 08/19/2005
This revision is to correct a typographical error in Revision #10. Federally Qualified Health Centers should be abbreviated FQHC not HQHC. This revision will become effective on 08/19/2005.

Revision #10, 08/19/2005
This policy was converted to a Local Coverage Determination as directed per change request 3010.
Under CMS National Coverage Policy section of this policy the following citations have been deleted as they relate to screening Pap smears not diagnostic Pap smears:
Balanced Budget Act (BBA) of 1997, section 4102 (screening Pap smear and pelvic exam)

Benefits Improvement and Protection Act of 2000, Title 1, Section 101.

Program Memorandum, Transmittal AB-02-163, dated November 8, 2002, Change Request 2420

These citations were added:
Title XVIII of the Social Security Act, section 1862 (a)(1)(A) allows coverage and payment for only those services that are considered to be reasonable and necessary for the diagnosis or treatment of illness or injury or to improve the functioning of a malformed body member.

CMS Manual System, Pub. 100-08, Medicare Program Integrity, Transmittal 62, dated January 23, 2004, Change Request 3010

Under Indications and Limitations of Coverage and/or Medical Necessity section the language found in the National Coverage Decision (NCD) was removed. Under the section Types of Bill Codes Federally Qualified Health Centers (HQHCs) was added. Under the Revenue Codes section 0923 for Pap smears was added. Under Utilization Guidelines section the reference to the BBA regarding screening Pap smears is listed. The Sources of Information and Basis for Decision section also contained the reference to the BBA; therefore it was deleted from here. This revision becomes effective 08/19/2005.


Revision #9, 11/22/2004
Under AMA CPT Copyright Statement section of this policy, deleted reference to CDT-4 copyright language as this policy does not contain CDT-4 codes or descriptions. Under ICD-9 Codes That Do Not Support Medical Necessity section of this policy deleted the verbiage related to Appeal rights, as this information will appear on the Palmetto GBA web site under Appeals information. These changes become effective 11/22/2004.

Under CPT/HCPCS Codes there were a verbiage change to CPT code 88141. This change becomes effective 01/01/2005.

Revision #8, 10/01/2004
Under AMA CPT Copyright Statement changed the copyright date from 2003 to 2004. Added the American Dental Association copyright statement. Under CMS National Coverage Policy section of this policy deleted Change Requests 1661 and 1021. Added Program Memorandum Transmittal AB-02-163 dated November 8, 2002, Change Request 2420, Benefits Improvement and Protection Act of 2000, Title 1, Section 101 and CMS Manual System, Pub 100-3, Medicare National Coverage Determinations Manual, Chapter 1, Part 3, Section 190.2 and Part 4, Section 230.11 Under Benefit Category changed the verbiage from Screening Pap Smear to Diagnostic Laboratory Tests. Under CPT/HCPCS Codes added CPT codes 88174 and 88175 per Change Request 2420. Under ICD-9 Codes That Support Medical Necessity extended ICD-9 code 622.1 to 622.10. Added ICD-9 codes 622.11, 622.12, 795.03, 795.04, 795.05, and 795.08. Verbiage changed for ICD-9 codes 795.00, 795.01, 795.02, and 795.09. Under Other Comments added statement #4 to indicate screening frequency for pelvic exams from once every 3 years to once every 2 years. Added NCD citation for statement #5 and changed Local Medical Review Policy to Local Coverage Determination. These changes become effective 10/01/2004.

Revision #7, 11/28/2003
Under CMS National Coverage Policy section of this policy the manual citation has been changed to reflect the Internet Only Manual (IOM). This change becomes effective 11/28/2003.

Revision #6, 10/01/2003
The copyright date was changed to 2003 under the section AMA CPT Copyright Statement. CMS Pub. 100-8, Medicare Program Integrity, Transmittal 44, dated July 25, 2003, Change Request 2592 was added under the section CMS National Coverage Policy. These changes will become effective 10/01/2003.

Revision #5, 08/23/2002
ICD-9-CM code 795.0 has been changed to include the 5th digit 795.00. ICD –9-Cm codes, 795.01, 795.02, and 795.09 have been added to the list of ICD-9-CM Codes That Support Medical Necessity section of this policy. Under Type of Bill Code section, Critical Access Hospital (85x) has been added to the policy. Deleted CPT codes, 88144 and 88145 under CPT/HCPCS CODES section of this policy. These changes become effective 10/01/2002.

Revision #4 08/10/2001
Policy format has been revised to be consistent with changes set forth in Program Integrity Manual Transmittal #9, Change Request 1021, Dated July 30, 2001. ICD-9-CM codes have been reviewed and updated as per Program Memorandum Transmittal AB-01-91, Change Request 1661, Dated June 28, 2001.

Revision #3 05/23/1999
Cited in the policy

Revision #2 02/24/1999
Reflects changes to CPT and ICD-9-CM codes and coding guidelines.

Revision #1



This LCD was converted from an LMRP on 7/19/2005



11/09/2008 - The description for CPT/HCPCS code 88155 was changed in group 1 
 
Reason for Change back to top
HCPCS/ICD9 Descriptor Change
ICD9 Addition/Deletion
 
Last Reviewed On Date back to top
09/18/2008 
 
Related Documents back to top
This LCD has no Related Documents.
 
LCD Attachments back to top
There are no attachments for this LCD.


All Versions back to top
Superceded StampSuperceded Stamp
Updated on 07/31/2009 with effective dates 09/03/2009 - N/A
Updated on 11/09/2008 with effective dates 10/01/2008 - 09/02/2009
Updated on 09/19/2008 with effective dates 10/01/2008 - N/A
Updated on 02/18/2008 with effective dates 10/01/2007 - 09/30/2008
Updated on 09/21/2007 with effective dates 10/01/2007 - N/A
Some older versions have been archived. Please visit the MCD Archive Site to retrieve them.

Read the LCD Disclaimer

basket Add to basket  |  envelope icon - email Email this to a friend  |  new search New Search



Page Last Modified: 11/30/2009 8:47:16 AM

Help with File Formats and Plug-Ins

Submit Feedback





www2